The average one-year price target for PDS Biotechnology (NASDAQCM:PDSB) has been revised to $4.25 / share. This is a decrease of 13.79% from the prior estimate of $4.93 dated August 25, 2026. These ...

On the lookout for a Sector - Health fund? Starting with Franklin Biotechnology Discovery A (FBDIX) is one possibility. FBDIX has a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on various ...

Matica Biotechnology ("Matica Bio"), a Texas-based contract development and manufacturing organization (CDMO) specializing in cell and gene therapy, today announced a collaboration with Bondwell ...

Meroueh may have found a way to clean up steelmaking without driving up the price. Her new furnace turns iron ore into ...

"Biotechnology" is a term commonly applied to the development of new medicines and therapies, the development of genetically modified plants, biofuels, biological treatment, or the production of ...

Microbial biotechnology is a dynamic field, The origins of microbiology can be traced back to the pioneering research by scientists such as Louis Pasteur and Robert Koch in the 19 th century. Within a ...

PDS Biotechnology (PDSB) said Monday it has raised about $11.3 million from an initial closing of a private financing, with Nant Capital leading the round. The company said it sold shares, pre-funded ...

The convergence of AI and biotechnology blurs boundaries and challenges existing regulations designed to consider technologies separately.

The field of biotechnology has always transformed cutting-edge science into life-changing medicines, but today that transformation is happening at a staggering pace. New discoveries are faster, ...

Nautilus Biotechnology, Inc. ( NAUT ), a development-stage life sciences company focused on single-molecule proteomics, on Friday announced a peer-reviewed publication in Nature Methods demonstrating ...

China is simply building up its technological capabilities, strengthening its domestic industrial chains, and pursuing steady ...